Section 116 Whenever a punishment has been inflicted under Section 89, Section 90, Section 98, Section 99, Section 100 or Section 101, all psychotropic substances, tools and equipment used in their production including containers or packages connected with the offence shall be forfeited and forwarded to the Ministry of Public Health for destruction or management as it thinks fit.

Section 117 The Secretary-General or the person entrusted by him shall have the power to settle all offences punishable only with fines under this Act.

Transitory Provisions

Section 118 A licensee to produce, sell or import any drug which is psychotropic substance or contains a psychotropic substance under the law on drugs on the date this Act comes into force may continue his business until his license expires and if he wishes to continue business thereafter, he shall file an application for a license under this Act within sixty days from the date this Act comes into force. Within the aforesaid period, the applicant may continue his business for the time being, but if the grantor issues a written order refusing to grant him a license, such person shall not be entitled to continue his business as from the date of the knowledge of the order and the provisions of Section 58 shall apply mutatis mutandis thereto.

Section 119 All drugs which, being psychotropic substances or containing psychotropic substances, have been duly produced, sold or imported under the law on drugs or the law on harmful habit forming drugs on the date this Act comes into force shall not be required to have the statement “psychotropic substance” under Section 27 (3) within one year from the date this Act comes into force.

Countersigned by
Sanya Dharmasakti
Prime Minister
Certified correct translation
(Surapol Trivate)
Legal and Scientific Detection Division
Office of the Narcotics Control Board
Office of the Prime Minister

Lists under the Notification
of the Ministry of Public Health
No. 97 (B.E. 2539)* specifying
names and categories of psychotropic
substances according to Psychotropic
Substances Act B.E. 2518 (1975)

Schedule 1
1. CATHINONE ((-)-a-Amino-propiophenone)

2. DET (N,N-Diethyltryptamine)

3. DMHP (3-(1,2 Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9
trimethyl-6H-dibenzo [b,d] pyran)

4. DMT (N,N-Dimethyltryptamine)

5. MESCALINE (3,4,5-Trimethoxyphenethylamine)

6. 4-METHYL AMINOREX ((+)-cis-2-Amino-4-methyl-5-phenyl-2-oxazoline or
(+)- cis-4,5- Dihydro-4-methyl-5-phenyl-2-oxazolamine)

7. N-ethyl MDA or MDE ((+)-N-Ethyl-a-methyl-3,4-(methylenedioxy)phenethylamine)

8. N-hydroxy MDA or N-OHMDA ((+)-N-[a-Methyl-3,4-(methylenedioxy)
phenethyl] hydroxylamine)

9. PARAHEXYL (3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo
[b,d] pyran)

10. PCE (N-ethyl-1-phenylcyclohexylamine)

11. PHP or PCPY (1-(1-Phenylcyclohexyl) pyrrolidine)

12. PSILOCINE (3-(2-Dimethylaminoethyl)-4-hydroxyindole)

13. PSILOCYBINE (3-(2-Dimethylaminoethyl)-indol-4-yl dihydrogen phosphate)

14. STP or DOM (2-amino-1-(2,5-Dimethoxy-4-methyl) phenylpropane)

15. TCP (1-[1-(2-Thienyl) cyclohexyl] piperidine)

16. TETRAHYDROCANNABI-NOL (1-Hydroxy-3-pentyl-6 a, 7,10,10 a-tetrahydro-6,6,9-trimethyl-6H-dibenzo [b,d] pyran)

⁽²⁾17.ETRYPTAMINE (3-(2-aminobutyl) indole)

18. METHCATHINONE (2-(methylamino)-1-phenylpropan-1-one)

Next Page
[1]  [2] [3] [4]  [5] [6] [7]  [8] [9] [10]  [11] [12] [13] [14]

* Published in the Government Gazette Vol.113, Special part 23 Ngor., dated 16th August B.E.2539 (1996).

(2) No.17 and 18 are added by the Notification of the Ministry of Public Health No.98 (B.E.2540), published in the Government Gazette Vol. 114, Part, 18 Ngor., dated 4th March B.E.2540 (1997)